Hemispherx Biopharma, Inc.

Hemispherx Biopharma, Inc. company information, Employees & Contact Information

Hemispherx Biopharma, Inc. is an advanced specialty pharmaceutical company engaged in the clinical development of new drug entities for treatment of seriously debilitating disorders. Hemispherx’s flagship products include Alferon N Injection® and the experimental therapeutics Ampligen®. Ampligen® is an experimental RNA nucleic acid being developed for globally important debilitating diseases and disorders of the immune system, including Chronic Fatigue Syndrome. Hemispherx’s platform technology includes components for potential treatment of various severely debilitating and life threatening diseases. Because Ampligen® is experimental in nature, they are not designated safe and effective by a regulatory authority for general use and are legally available only through clinical trials. The FDA approval of Alferon N Injection® is limited to the treatment of refractory or recurrent external genital warts in patients 18 years of age or older. The Company’s Alferon® N approval in Argentina includes the use of Alferon N Injection® (under the brand name “Naturaferon”) for use in any patients who fail, or become intolerant to recombinant interferon, including patients with chronic active hepatitis C infection. The Company exclusively operates a GMP certified manufacturing facility in the United States for commercial products.

Company Details

Employees
46
Founded
-
Address
2117 Sw Highway 484, Ocala,florida,united States
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Ocala, Florida
Looking for a particular Hemispherx Biopharma, Inc. employee's phone or email?

Hemispherx Biopharma, Inc. Questions

News

Hemispherx Bio To Present At Rodman & Renshaw Conference; Webcast At 3:40 PM ET - RTTNews

Hemispherx Bio To Present At Rodman & Renshaw Conference; Webcast At 3:40 PM ET RTTNews

Hemispherx Receives the European Patent Office Examining - GlobeNewswire

Hemispherx Receives the European Patent Office Examining GlobeNewswire

Hemispherx Fires Chairman and CEO - Genetic Engineering and Biotechnology News

Hemispherx Fires Chairman and CEO Genetic Engineering and Biotechnology News

Hemispherx Biopharma To Present At The Maxim Group 3rd Annual Growth Conference; Webcast At 11:30 AM - RTTNews

Hemispherx Biopharma To Present At The Maxim Group 3rd Annual Growth Conference; Webcast At 11:30 AM RTTNews

Hemispherx Presents New Data on Protection From Pulmonary - GlobeNewswire

Hemispherx Presents New Data on Protection From Pulmonary GlobeNewswire

Hemispherx Biopharma Q3 Loss Narrows - Quick Facts - RTTNews

Hemispherx Biopharma Q3 Loss Narrows - Quick Facts RTTNews

Hemispherx Biopharma FY11 Loss Narrows - RTTNews

Hemispherx Biopharma FY11 Loss Narrows RTTNews

Hemispherx Biopharma Q1 loss narrows - Quick Facts - RTTNews

Hemispherx Biopharma Q1 loss narrows - Quick Facts RTTNews

Hemispherx Biopharma Q3 loss narrows - Quick Facts - RTTNews

Hemispherx Biopharma Q3 loss narrows - Quick Facts RTTNews

Hemispherx Biopharma Q1 Loss Narrows - Quick Facts - RTTNews

Hemispherx Biopharma Q1 Loss Narrows - Quick Facts RTTNews

Top Hemispherx Biopharma, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant